Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in ratsPANES, J; MOLLA, M; CASADEVALL, M et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 6, pp 841-850, issn 0269-2813Article

N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenaseCONNOLLY, P. J; WELTER, S. K; ARGENTIERI, D. C et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 7, pp 979-984, issn 0960-894XArticle

Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammationKIRCHNER, T; APARICIO, B; ARGENTIERI, D. C et al.Prostaglandins, leukotrienes and essential fatty acids. 1997, Vol 56, Num 6, pp 417-423, issn 0952-3278Article

Validation of an HPLC-FL Method for the Determination of Tepoxalin and its Major Metabolite in Horse PlasmaGIORGI, Mario; GUISHENG YE; SGORBINI, Micaela et al.Journal of chromatographic science. 2011, Vol 49, Num 1, pp 79-83, issn 0021-9665, 5 p.Article

Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin : anti-inflammatory without gastropathy ?WALLACE, J. L; MCCAFFERTY, D.-M; CARTER, L et al.Gastroenterology (New York, NY. 1943). 1993, Vol 105, Num 6, pp 1630-1636, issn 0016-5085Article

Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in manDEPRE, M; VAN HECKEN, A; VERMYLEN, J et al.International journal of clinical pharmacology research. 1996, Vol 16, Num 1, pp 1-8, issn 0251-1649Article

The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha₁-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alphaFIEBICH, B. L; HOFER, T. J; LIEB, K et al.Neuropharmacology. 1999, Vol 38, Num 9, pp 1325-1333, issn 0028-3908Article

Characterization of tepoxalin and its related compounds by high-performance liquid chromatography/mass spectrometryBURINSKY, D. J; ARMSTRONG, B. L; OYLER, A. R et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 2, pp 159-164, issn 0022-3549Article

Antinociceptive effects of a novel dual cyclooxygenase/5-lipoxygenase inhibitor (tepoxalin) and its primary (carboxylic acid) metabolite (RWJ 20142) in acute tests in mice and ratsRAFFA, R. B; CONNELLY, C. D; MARTINEZ, R. P et al.Drug development research. 1995, Vol 36, Num 2, pp 81-90, issn 0272-4391Article

Cytokine-modulating activity of tepoxalin, a new potential antirheumaticRITCHIE, D. M; ARGENTIERI, D. C; APARICIO, B. L et al.International journal of immunopharmacology. 1995, Vol 17, Num 10, pp 805-812, issn 0192-0561Article